Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI107637

Uptake and Utilization of Exogenous Cystine by Cystinotic and Normal Fibroblasts

Beatrice States, Dorothy Harris, and Stanton Segal

Division of Biochemical Development and Molecular Diseases, Children's Hospital of Philadelphia, Pennsylvania 19146

Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19146

Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19146

Find articles by States, B. in: PubMed | Google Scholar

Division of Biochemical Development and Molecular Diseases, Children's Hospital of Philadelphia, Pennsylvania 19146

Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19146

Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19146

Find articles by Harris, D. in: PubMed | Google Scholar

Division of Biochemical Development and Molecular Diseases, Children's Hospital of Philadelphia, Pennsylvania 19146

Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19146

Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19146

Find articles by Segal, S. in: PubMed | Google Scholar

Published April 1, 1974 - More info

Published in Volume 53, Issue 4 on April 1, 1974
J Clin Invest. 1974;53(4):1003–1016. https://doi.org/10.1172/JCI107637.
© 1974 The American Society for Clinical Investigation
Published April 1, 1974 - Version history
View PDF
Abstract

The uptake of l-[35S]cystine was studied in six cystinotic and six normal fibroblast lines grown for five days either on cover slips or in 32-oz plastic flasks. Cystinotics showed greater uptake than normals. The apparent Kt for cystine entry in both types of cells was 0.043 mM but cystinotic cells showed a higher maximum velocity of entry. A comparison of the fate of l-[35S]cystine incubated for 20 min with monolayers of cells showed 30% and 15% of the intracellular 35S to be l-cystine in cystinotic and normal cells, respectively. The 35S effluxed more slowly from cystinotic than from normal cells after a 20-min preloading with l-[35S]cystine. Identification of 35S compounds in efflux media after 3 min showed 75% of the total 35S was l-cystine with the remainder in cysteine and acidic sulfur metabolites of cystine with no essential difference between cystinotics and normals. In paired experiments, the specific activity of the effluxed l-[35S]cystine after both efflux periods was the same as that entering the cell, thus indicating that the free l-[35S]cystine had not exchanged with the pre-existing pool in the cystinotic cells. During 3 min efflux, the l-cystine pool in normal cells was depleted mainly by loss of free cystine. In cystinotic cells, a new steady state was attained after 21 min of efflux and the intracellular l-[35S]cystine had the same percentage of total radioactivity seen after the initial 20-min uptake. After the rapid efflux of l-[35S]cystine from normals, [35S]cysteine and other labeled cystine metabolites appeared in the efflux media. By the end of a 3-min efflux, cystinotic cells had incorporated more label into reduced glutathione than had normal cells. However, when the new steady state was attained in cystinotics, the amounts of 35S in glutathione were not markedly different in the two types of cells. Approximately 95% of the total label could be accounted for in free sulfur compounds.

The data show an increased uptake and decreased efflux of cystine from cystinotic cells. However, it is not possible to conclude if these differences are due to primary changes in membrane function or to the reflection of metabolic defects without further investigation.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1003
page 1003
icon of scanned page 1004
page 1004
icon of scanned page 1005
page 1005
icon of scanned page 1006
page 1006
icon of scanned page 1007
page 1007
icon of scanned page 1008
page 1008
icon of scanned page 1009
page 1009
icon of scanned page 1010
page 1010
icon of scanned page 1011
page 1011
icon of scanned page 1012
page 1012
icon of scanned page 1013
page 1013
icon of scanned page 1014
page 1014
icon of scanned page 1015
page 1015
icon of scanned page 1016
page 1016
Version history
  • Version 1 (April 1, 1974): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts